Highlights ProPhase Labs, Inc.

Equities

PRPH

US74345W1080

Real-time Estimate Cboe BZX Other stock markets 15:04:31 2024-05-13 EDT			5-day change	1st Jan Change
5.185 ^USD	+2.67%		-1.87%	+15.93%

05-09	Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M	MT
05-09	Transcript : ProPhase Labs, Inc., Q1 2024 Earnings Call, May 09, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M	05-09	MT
Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M	05-09	MT
ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup	04-16	DJ
ProPhase Labs, Inc. Unveils Project ZenQ-AI	04-16	CI
ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-15	CI
North American Morning Briefing : Inflation -2-	03-15	DJ
Prophase Labs, Inc. Announces Important Developments in the Company?s Efforts to Commercialize Its Novel Be-Smart Esophageal Cancer Diagnostic Test	02-20	CI
ProPhase Labs, Inc. Announces Preliminary Positive Results for Dietary Supplement Equivir	02-14	CI
Tranche Update on ProPhase Labs, Inc.'s Equity Buyback Plan announced on March 15, 2023.	11-13	CI
Earnings Flash (PRPH) PROPHASE LABS Posts Q3 Revenue $8.4M	11-09	MT
ProPhase Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
ProPhase Labs, Inc.'s Equity Buyback announced on March 15, 2023, has expired with 69,628 shares, representing 0.43% for $0.59 million.	23-09-14	CI
Tranche Update on ProPhase Labs, Inc.'s Equity Buyback Plan announced on March 15, 2023.	23-08-11	CI
Earnings Flash (PRPH) PROPHASE LABS Reports Q2 Revenue $13.2M	23-08-10	MT
ProPhase Labs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Navidea Biopharmaceuticals Confirms Rejection of ProPhase Labs' Proposal to Buy Some of Its Assets	23-06-30	MT
ProPhase Labs Says Offer to Acquire Certain Navidea Biopharmaceuticals' Assets Rejected	23-06-29	MT
ProPhase Labs, Inc. cancelled the acquisition of Certain Assets from Navidea Biopharmaceuticals, Inc. for $7 million.	23-06-28	CI
ProPhase Labs, Inc Provides an Update Regarding Its Progress and Development Strategy for Linebacker-1	23-06-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ProPhase Labs, Inc.

Equities

PRPH

US74345W1080

Highlights

Filters